Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 2
1991 2
1999 1
2000 2
2001 3
2002 6
2003 16
2004 14
2005 16
2006 30
2007 22
2008 27
2009 27
2010 24
2011 32
2012 42
2013 36
2014 41
2015 30
2016 31
2017 39
2018 24
2019 33
2020 26
2021 17
2022 29
2023 28
2024 26
2025 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

546 results

Results by year

Filters applied: . Clear all
Page 1
Deep learning predicts EGFR mutation status from histology images in non-small cell lung cancer.
Park J, Shin S, Hwang W, Keum S, Brattoli B, Rawson JH, Lee T, Pereira S, Ahn CH, Senior MJT, Qaiser T, Kim S, Kim H, Chung JH, Choi YL, Lee SH, Bannister H, Riboni-Verri E, Ock CY, Hill RJ, Ali S, Moore L. Park J, et al. Among authors: choi yl. Cancer Res Commun. 2025 Nov 10. doi: 10.1158/2767-9764.CRC-25-0155. Online ahead of print. Cancer Res Commun. 2025. PMID: 41211715 Free article.
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.
Bang YH, Park GH, Oh JW, Hwang S, Jeong JG, Lee B, Joe CY, Kim H, Kim J, Park S, Jung HA, Sun JM, Ahn JS, Ahn MJ, Choi YL, Ahn CH, Ali SM, Ock CY, Lee SH. Bang YH, et al. Among authors: choi yl. J Immunother Cancer. 2025 Oct 31;13(10):e012374. doi: 10.1136/jitc-2025-012374. J Immunother Cancer. 2025. PMID: 41173494 Free PMC article.
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.
Kim J, Bang YH, Park S, Jung HA, Sun JM, Ahn JS, Ahn MJ, Jeon YJ, Lee J, Cho JH, Kim HK, Choi YS, Zo JI, Shim YM, Kang JH, Lee J, Choi YL, Han J, Hwang S, Lee HY, Lee SH. Kim J, et al. Among authors: choi yl. EClinicalMedicine. 2025 Jun 4;84:103282. doi: 10.1016/j.eclinm.2025.103282. eCollection 2025 Jun. EClinicalMedicine. 2025. PMID: 40524802 Free PMC article.
Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
Park J, Chang ES, Kim JY, Chelakkot C, Sung M, Song JY, Jung K, Lee JH, Choi JY, Kim NY, Lee H, Kang MR, Kwon MJ, Shin YK, Park YH, Choi YL. Park J, et al. Among authors: choi yl. Breast Cancer Res. 2025 Jan 7;27(1):3. doi: 10.1186/s13058-024-01952-0. Breast Cancer Res. 2025. PMID: 39773237 Free PMC article. No abstract available.
546 results